WorldQuant Millennium Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

WorldQuant Millennium Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3M	Buy	55,396 +31,719	+134%	+$6.95M	0.05%	278
2026 Q1	$4.48M	Sell	23,677 -4,707	-17%	-$823K	0.02%	347
2025 Q4	$4.83M	Buy	+28,384	New	+$4.35M	0.02%	335
2025 Q1	–	Sell	-4,775	Closed	-$588K	–	464
2024 Q4	$588K	Hold	4,775	–	–	﹤0.01%	399
2024 Q3	$532K	Hold	4,775	–	–	﹤0.01%	398
2024 Q2	$510K	Sell	4,775 -44,009	-90%	-$4.84M	﹤0.01%	373
2024 Q1	$5.87M	Sell	48,784 -116,185	-70%	-$14.2M	0.07%	233
2023 Q4	$20.3M	Buy	164,969 +65,638	+66%	+$8.19M	0.28%	111
2023 Q3	$12.9M	Sell	99,331 -13,179	-12%	-$1.76M	0.2%	149
2023 Q2	$13.9M	Buy	112,510 +53,030	+89%	+$7.13M	0.24%	140
2023 Q1	$8.7M	Buy	+59,480	New	+$8.8M	0.16%	173
2020 Q1	–	Sell	-10,942	Closed	-$1.63M	–	338
2019 Q4	$1.63M	Sell	10,942 -781	-7%	-$106K	0.03%	275
2019 Q3	$1.5M	Sell	11,723 -364	-3%	-$48.8K	0.03%	268
2019 Q2	$1.72M	Buy	12,087 +1,516	+14%	+$204K	0.03%	236
2019 Q1	$1.51M	Buy	+10,571	New	+$1.38M	0.04%	237

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

WorldQuant Millennium Advisors's JAZZ Position: Q2 2026 in Review

WorldQuant Millennium Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 134% in Q2 2026, buying an estimated $6.95M and bringing the position to 55,396 shares worth $13.3M. The position accounts for 0.05% of the portfolio, ranked #278.

WorldQuant Millennium Advisors first reported a position in JAZZ in Q1 2019 and has held it in 15 quarters since. The position peaked at $20.3M in Q4 2023. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

WorldQuant Millennium Advisors held 55,396 shares of Jazz Pharmaceuticals worth $13.3M as of Q2 2026.
WorldQuant Millennium Advisors bought 31,719 Jazz Pharmaceuticals shares in Q2 2026, an estimated $6.95M.
Jazz Pharmaceuticals made up 0.05% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #278 holding.
WorldQuant Millennium Advisors first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
WorldQuant Millennium Advisors's Jazz Pharmaceuticals position peaked at $20.3M in Q4 2023.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.